Previously, we identified anti-EPOR antibodies in patients with various kidney diseases, including diabetic kidney disease.4, 5, 6, 7 Although the pathogenic mechanisms underlying the development of autoantibodies in patients with T2D are unclear, anti-EPOR antibodies were associated with kidney disease progression in patients with diabetes.5 This evidence concerns the gene EPOR and diabetes mellitus.